Does ENZALUTAMIDE Cause Urinary retention? 190 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Urinary retention have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.4% of all adverse event reports for ENZALUTAMIDE.
190
Reports of Urinary retention with ENZALUTAMIDE
0.4%
of all ENZALUTAMIDE reports
29
Deaths
82
Hospitalizations
How Dangerous Is Urinary retention From ENZALUTAMIDE?
Of the 190 reports, 29 (15.3%) resulted in death, 82 (43.2%) required hospitalization, and 2 (1.1%) were considered life-threatening.
Is Urinary retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 190 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Urinary retention?
MIRABEGRON (706)
QUETIAPINE (617)
TAMSULOSIN (475)
ADALIMUMAB (452)
MORPHINE (407)
OLANZAPINE (405)
SERTRALINE (380)
PREGABALIN (376)
RISPERIDONE (375)
DULOXETINE (362)
Which ENZALUTAMIDE Alternatives Have Lower Urinary retention Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE